Re: Should we screen for lung cancer in Australia?

Medical Journal of Australia

Volumn 199, Issue 9, 2013, Pages 586-

  Hew, Mark ^a   Stirling, Robert G ^a   Abramson, Michael J ^b  

^a The Alfred   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AUSTRALIA; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; HUMAN; LETTER; LUNG CANCER; MEDICARE; QUALITY ADJUSTED LIFE YEAR; SMOKING; SMOKING CESSATION;

EID: 84887325530     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja13.11158     Document Type: Letter

References (6)

1. National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365: 395-409.
2. Bach PB, Gould MK, Silvestri GA. Computed tomography screening for lung cancer. Ann Intern Med 2013; 159: 155-156.
3. Field JK, Oudkerk M, Pedersen JH, Duffy SW. Prospects for population screening and diagnosis of lung cancer. Lancet 2013; 382: 732-741.
4. Manser R, Lethaby A, Irving LB, et al. Screening for lung cancer. Cochrane Database Syst Rev 2013; (6): CD001991.
5. Hew M, Stirling RG, Abramson MJ. Should we screen for lung cancer in Australia [editorial]? Med J Aust 2013; 199: 82-83.
6. Moolgavkar SH, Holford TR, Levy DT, et al. Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000. J Natl Cancer Inst 2012; 104: 541-548.